Current pharmacotherapy options for labor induction

J. Seth Hawkins, Deborah A. Wing

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Introduction: Labor induction is now reported to occur in up to 30 40% of obstetrical patients. There are a number of pharmacological options available to facilitate labor induction, including oxytocin and analogues of prostaglandins E1 and E2, which have particular utility when labor induction necessitates cervical ripening, as when labor induction occurs in the context of an unfavorable cervix. Areas covered: This paper reviews acceptable pharmacological options for labor induction, especially when cervical ripening is required. These options include oxytocin and a number of prostaglandin formulations using dinoprostone and misoprostol. It also covers several analyses of published clinical trials (Phase-III) describing evidence of effectiveness. Expert opinion: Oxytocin is best used when labor needs to be induced in the context of a favorable cervix. When the cervix is not favorable, cervical ripening using prostaglandins should precede labor induction. Either dinoprostone or misoprostol are superior to oxytocin alone for cervical ripening. However, judicious, careful considerations need to be made at the outset of labor induction so as to balance maternal and fetal risks, and these should be guided by institutional policies that reflect the evidence-base.

Original languageEnglish (US)
Pages (from-to)2005-2014
Number of pages10
JournalExpert Opinion on Pharmacotherapy
Volume13
Issue number14
DOIs
StatePublished - Oct 2012

Fingerprint

Induced Labor
Cervical Ripening
Drug Therapy
Oxytocin
Dinoprostone
Cervix Uteri
Misoprostol
Prostaglandins
Pharmacology
Organizational Policy
Phase III Clinical Trials
Alprostadil
Expert Testimony
Mothers

Keywords

  • Induction
  • Labor
  • Oxytocin
  • Prostaglandin

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Current pharmacotherapy options for labor induction. / Hawkins, J. Seth; Wing, Deborah A.

In: Expert Opinion on Pharmacotherapy, Vol. 13, No. 14, 10.2012, p. 2005-2014.

Research output: Contribution to journalArticle

Hawkins, J. Seth ; Wing, Deborah A. / Current pharmacotherapy options for labor induction. In: Expert Opinion on Pharmacotherapy. 2012 ; Vol. 13, No. 14. pp. 2005-2014.
@article{7adce9175a5f4490982577c6ded0f397,
title = "Current pharmacotherapy options for labor induction",
abstract = "Introduction: Labor induction is now reported to occur in up to 30 40{\%} of obstetrical patients. There are a number of pharmacological options available to facilitate labor induction, including oxytocin and analogues of prostaglandins E1 and E2, which have particular utility when labor induction necessitates cervical ripening, as when labor induction occurs in the context of an unfavorable cervix. Areas covered: This paper reviews acceptable pharmacological options for labor induction, especially when cervical ripening is required. These options include oxytocin and a number of prostaglandin formulations using dinoprostone and misoprostol. It also covers several analyses of published clinical trials (Phase-III) describing evidence of effectiveness. Expert opinion: Oxytocin is best used when labor needs to be induced in the context of a favorable cervix. When the cervix is not favorable, cervical ripening using prostaglandins should precede labor induction. Either dinoprostone or misoprostol are superior to oxytocin alone for cervical ripening. However, judicious, careful considerations need to be made at the outset of labor induction so as to balance maternal and fetal risks, and these should be guided by institutional policies that reflect the evidence-base.",
keywords = "Induction, Labor, Oxytocin, Prostaglandin",
author = "Hawkins, {J. Seth} and Wing, {Deborah A.}",
year = "2012",
month = "10",
doi = "10.1517/14656566.2012.722622",
language = "English (US)",
volume = "13",
pages = "2005--2014",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "14",

}

TY - JOUR

T1 - Current pharmacotherapy options for labor induction

AU - Hawkins, J. Seth

AU - Wing, Deborah A.

PY - 2012/10

Y1 - 2012/10

N2 - Introduction: Labor induction is now reported to occur in up to 30 40% of obstetrical patients. There are a number of pharmacological options available to facilitate labor induction, including oxytocin and analogues of prostaglandins E1 and E2, which have particular utility when labor induction necessitates cervical ripening, as when labor induction occurs in the context of an unfavorable cervix. Areas covered: This paper reviews acceptable pharmacological options for labor induction, especially when cervical ripening is required. These options include oxytocin and a number of prostaglandin formulations using dinoprostone and misoprostol. It also covers several analyses of published clinical trials (Phase-III) describing evidence of effectiveness. Expert opinion: Oxytocin is best used when labor needs to be induced in the context of a favorable cervix. When the cervix is not favorable, cervical ripening using prostaglandins should precede labor induction. Either dinoprostone or misoprostol are superior to oxytocin alone for cervical ripening. However, judicious, careful considerations need to be made at the outset of labor induction so as to balance maternal and fetal risks, and these should be guided by institutional policies that reflect the evidence-base.

AB - Introduction: Labor induction is now reported to occur in up to 30 40% of obstetrical patients. There are a number of pharmacological options available to facilitate labor induction, including oxytocin and analogues of prostaglandins E1 and E2, which have particular utility when labor induction necessitates cervical ripening, as when labor induction occurs in the context of an unfavorable cervix. Areas covered: This paper reviews acceptable pharmacological options for labor induction, especially when cervical ripening is required. These options include oxytocin and a number of prostaglandin formulations using dinoprostone and misoprostol. It also covers several analyses of published clinical trials (Phase-III) describing evidence of effectiveness. Expert opinion: Oxytocin is best used when labor needs to be induced in the context of a favorable cervix. When the cervix is not favorable, cervical ripening using prostaglandins should precede labor induction. Either dinoprostone or misoprostol are superior to oxytocin alone for cervical ripening. However, judicious, careful considerations need to be made at the outset of labor induction so as to balance maternal and fetal risks, and these should be guided by institutional policies that reflect the evidence-base.

KW - Induction

KW - Labor

KW - Oxytocin

KW - Prostaglandin

UR - http://www.scopus.com/inward/record.url?scp=84866253533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866253533&partnerID=8YFLogxK

U2 - 10.1517/14656566.2012.722622

DO - 10.1517/14656566.2012.722622

M3 - Article

C2 - 22963686

AN - SCOPUS:84866253533

VL - 13

SP - 2005

EP - 2014

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 14

ER -